News | November 17, 2022
During the Slush 2022, Algorithmiq has launched Aurora, the drug discovery platform on the founders stage. At Algorithmiq, we aim to demonstrate quantum advantage on chemistry simulations for the first time with hardware-agnostic software.
We believe, that the development of Aurora will help to realize a paradigm shift in drug discovery and development, enabling us to revolutionize the way new drugs are discovered, so they can be brought to market quickly, efficiently, and cost-effectively.
Aurora is available for commercial partners.
Get to know Aurora: